Gonadal function in men with testicular cancer: Biological and clinical aspects

APMIS

Volumn 106, Issue 1, 1998, Pages 24-36

  Petersen, Peter Meidahl ^a   Skakkebæk, Niels E ^a   Giwercman, Aleksander ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Fertility; Leydig cell function; Spermatogenesis; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VINBLASTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; CONFERENCE PAPER; CRYPTORCHISM; GERM CELL TUMOR; GONAD DYSFUNCTION; HORMONE DEFICIENCY; HUMAN; LEYDIG CELL; LYMPH NODE DISSECTION; MALE INFERTILITY; ORCHIECTOMY; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTIVE TOXICITY; SPERMATOGENESIS; SPERMATOZOON COUNT; TERATOGENICITY; TESTIS CANCER;

EID: 0031915230     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01316.x     Document Type: Conference Paper

References (64)

1. Aass, N., Fosså, S. D., Theodoresen, L. & Norman, N.: Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur. J. Cancer 27: 1087-1091, 1991.
2. Adami, H., Bergström, R., Möhner, M., Zatonski, W., Storm, H., Ekhom, A., Tretli, S., Teppo, L., Ziegler, H., Rahu, M., et al.: Testicular cancer in nine Northern European countries. Int. J. Cancer 59: 33-38, 1994.
3. Auger, J., Kunstmann, J. M., Czyglik, F. & Jouannet, P.: Conservation du sperme avant traitement anticancereux. Une mesure efficace pour preserver les chances de conception future. Contraception., Fertilité et Sex 21: 749-752, 1993.
4. Auger, J., Kunstmann, J. M., Czyglik, F. & Jouannet, P.: Decline in semen quality among fertile men in Paris during the past 20 years. N. Engl. J. Med. 332: 281-285, 1995.
5. Bajorin, D. F., Sarosdy, M. F., Pfister, D. G., Mazumdar, M., Motzer, R. J., Scher, H. I., Geller, N. L., Fair, W. R., Herr, H. & Sogani, P.: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: a multiinstitutional study. J. Clin. Oncol. 11: 598-606, 1993.
6. Berthelsen, J. G. & Skakkebæk, N. E.: Gonadal function in men with testis cancer. Fertil. Steril. 39: 68-75, 1983.
7. Bokemeyer, C., Berger, C. C., Kuczyk, M. A. & Schmoll, H.-J.: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J. Clin. Oncol. 14: No 11: 2923-2932, 1996.
8. Bouchot, O., Plougastel, M. L. & Karam, G.: Sterilite et tumeurs du testicule. Journal d'Urologie 95: 367-371, 1989.
9. Bradely, L. N., Yarema, K. J., Lippard, S. J. & Essigmann, J. M.: Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diaminechloroplatinum. Biochem. 32: 982-988, 1993.
10. Bujan, L., Mansat, A., Pontonnier, F. & Mieusset, R.: Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. Br. Med. J. 312: 471-472, 1996.
11. Carlsen, E., Giwercman, A., Keiding, N. & Skakkebæk, N. E.: Evidence for decreasing quality of semen during the past 50 years. BMJ 305: 609-613, 1992.
12. Carroll, P. R., Whitmore, W. F. Jr., Herr, H. W., Morse, M. J., Sogani, P. C., Bajorunas, D., Fair, W. R. & Chaganti, R. S. K: Endocrine and exocrine profiles of men with testicular tumors before orchidectomy. J. Urol. 137: 420-423, 1987.
13. Centola, G. M., Keller, J. W., Henzler, M. & Rubin, P.: Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J. Androl. 15: 608-613, 1994.
14. Chilvers, C., Dudley, N. E., Cough, M. H., Jackson, M. B. & Pike, M. C. Undescended testis: The effect of treatment on subsequent risk of subfertility and malignancy. J. Pediatr. Surg. 21: 691-696, 1986.
15. Coogan, C. L., Hejase, M. J., Wahle, G. R., Foster, R. S., Rowland, R. G., Bihrle, R. & Donohue, J. P.: Post-orchidectomy nerve sparing retroperitoneal lymph node dissection for advanced testicular cancer. J. Urol. Nov. 156(5): 1656-1658, 1996.
16. Dearnaley, D. P., Harwich, A., A'Hern, R., Nicholls, J., Jay, G., Hendry, W. F. & Peckham, M. J.: Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long term follow-up. Eur. J. Cancer 27: 684-691, 1991.
17. Depue, R. H., Pike, M. C. & Henderson, B. E.: Estrogen exposure during gestation and risk of testicular cancer. J. Natl. Cancer Inst. 71: 1151-1155, 1983.
18. Dieckmann, K.-P. & Loy, V.: Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J. Clin. Oncol. 14: 3121-3125, 1996.
19. Dieckmann, K.-P. & Loy, V.: The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience. APMIS 106: 13-23, 1998.
20. Drasga, R. E., Einhorn, L. H. & Williams, S. D.: Fertility after chemotherapy for testicular cancer. J. Clin. Oncol. 1: 179-183, 1983.
21. Ford, F., Parkinson, M. C. & Pryor, J. P.: The undescended testis in adult life. Br. J. Urol. 57: 181-184, 1985.
22. Fosså, S. D., Ous, S., Åbyholm, T., Norman, N. & Loeb, M.: Post-treatment fertility in patients with testicular cancer. Br. J. Urol. 57: 210-214, 1985.
23. Fosså, S. D., Aass, N. & Molne, K.: Is routine pre-treatment cryopreservation of semen worthwile in the management of patients with testicular cancer? Br. J. Urol. 64: 524-529, 1989.
24. Fritz, K. & Weissbach, L.: Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil. Steril. 43: 451-454, 1985.
25. Giwercman, A., Grindsted, J., Hansen, B., Jensen, O. M. & Skakkebæk, N. E.: Testicular cancer risk in boys with maldescended testis: A cohort study. J. Urol. 138: 1214-1216, 1987.
26. Giwercman, A., von der Maase, H., Berthelsen, J. G., Rorth, M., Bertelsen, A. & Skakkebæk, N. E.: Localized irradiation of testes with carcinoma in situ: Effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J. Clin. Endocrinol. Metab. 73: 596-603, 1991.
27. Giwercman, A., von der Maase, H., Rerth, M. & Skakkebæk, N. E.: Semen quality in testicular tumour and CIS in the contralateral testis. Lancet 341: 384-385, 1993.
28. Hansen, P. V., Trykker, H., Andersen, J. & Helkjær, P. E.: Germ cell function and hormonal status in patients with testicular cancer. Cancer 64: 956-961, 1989a.
29. Hansen, P. V., Trykker. H., Helkjar, P. E. & Andersen, J.: Testicular function in patients with testicular cancer treated with orchidectomy alone or orchidectomy plus cisplatin-based chemotherapy. J. Natl. Cancer Inst. 81: 1246-1250, 1989b.
30. Hansen, P. V., Trykker, H., Svennekjær, I. L. & Hvolby, J.: Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother. Oncol. 18: 117-125, 1990a.
31. Hansen, S. W., Berthelsen, J. G. & von der Maase, H.: Longterm fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. J. Clin. Oncol. 8: 1695-1698, 1990b.
32. Hansen, P. V., Glavind, K., Panduro, J. & Pedersen, M.: Paternity in patients with testicular germ cell cancer: pretreatment and post-treatment findings. Eur. J. Cancer 27: 1385-1389, 1991.
33. Jensen, T. K., Giwercman, A., Carlsen, E., Scheike, T. & Skakkebæk, N. E.: Semen quality among members of organic food associations in Zealand, Denmark. Lancet 347: 1844, 1996.
34. Jewett, M. A. S., Thachil, J. V., Harris, J. F.: Exocrine function of testis with germinal testicular tumour. Br. Med. J. 286: 1849-1850, 1983.
35. Johnson, D. E., Hainsworth, J. D. & Linde, R. B.: Testicular function following combination chemotherapy with Cisplatin, vinblastine and bleomycin. Med. Pediatr. Oncol. 12: 233-238, 1984.
36. Kreuser, E. D., Harsch, U. & Hetzel, W. D.: Chronic gonadal toxicity in patients with testicular cancer after chemotherapy. Eur. J. Cancer Clin. Oncol. 22: 289-294, 1986.
37. Lampe, H., Harwich, A., Norman, A., Nicholls, J. & Dearnaley, D. P.: Fertility after chemotherapy for testicular germ cell cancer. J. Clin. Oncol. 15: 239-245, 1997.
38. Leitner, S. L., Bosl, G. J. & Bajorunas, D.: Gonadal dysfunction in patients treated for metastatic germ-cell tumors. J. Clin. Oncol. 4: 1500-1505, 1986.
39. Lähdetie, J., Keiski, A., Suutari, A. & Toppari, J.: Etoposide(VP-16) is a potent inducer of micronuclei in male rat meiosis. Environmental and molecular mutagenesis 24: 192-202, 1994.
40. Meistrich, M. L.: Potential genetic risks of using semen collected during chemotherapy. Hum. Reprod. 8: 8-10, 1993.
41. Moynihan, C.: Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv. 6: 477-510. 1987.
42. Müller, J.: Morphometry and histology of gonads from twelve children and adolescents with the androgen insensitivity (testicular feminization) syndrome. J. Clin. Endocrinol. Metab. 59: 785-789, 1984.
43. Moller, H., Prener, A. & Skakkebæk, N. E.: Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Contr. 7: 264-274, 1996.
44. Moller, H.: Trends in the sex-ratio., testicular cancer., and male reproductive hazards: are they connected. APMIS 106: 232-239, 1998.
45. Nijman, J. M., Schraffordt Koops, H., Kremer, J., Willemse, P. H. B., Sleijfer, D. T. & Oldhoff, J.: Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Archives of Andrology 14: 239-246, 1985.
46. Nijman, J. M., Schraffordt Koops, H., Kremer, J. & Sleijfer, D. T.: Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. J. Clin. Oncol. 5: 651 -656, 1987.
47. Nijman, J. M., Schraffordt Koops, H., Oldhoff, J., Kremer, J. & Sleijfer, D. T.: Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer. J. Surg. Oncol. 38: 182-186, 1988.
48. Palmieri, G., Lotrecchiano, G., Ricci, G., Spiezia. R., Lombardi, G., Bianco, A. R. & Torino, G.: Gonadal function after multimodality treatment in men with testicular germ cell cancer. Eur. J. Endocrinol. 134: 431-436, 1996.
49. Petersen, P. M., Hansen, S. W., Giwercman, A., Rnrth, M. & Skakkebæk, N. E.: Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann. Oncol. 5: 355-358, 1994.
50. Rowley, M. J., Leach, D. R., Warner, G. A. & Heller, C. G.: Effect of graded doses of ionizing radiation on the human testis. Radiat. Res. 59: 665-678, 1974.
51. Savage, M. O. & Lowe, D. G.: Gonadal neoplasia and abnormal sexual differentiation. Clin. Endocrinol. 32: 519-533, 1990.
52. Schmiegelow, M., Hansen, M. M. & Nielsen, N. C.: Kvalitet-en af kryopneserveret ejakulat ved Mb. Hodgkin. In Press. Ugeskr. Læger 1995.
53. Schottenfeld, D., Warshauer, M. E., Sherlock, S., Zauber, A. G., Leder, M. & Payne, R.: The epidemiology of testicular cancer in young adults. Am. J. Epidemiol. 112: 232-246, 1980.
54. Senturia, Y. D. & Peckham, C. S.: Children fathered by men treated with chemotherapy for testicular cancer. Eur. J. Cancer 26: 429-432, 1990.
55. Shalet, S. M., Tsatsoulis, A., Whitehead, E. & Read, G.: Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J. Endocrinol. 120: 161-165, 1989.
56. Shapiro, E., Kinsella, T. J., Makuch, R. W., Fraass, B. A., Glatstein, E., Rosenberg, S. A. & Sherins, R. J.: Effects of fractionaed irradiation on endocrine aspects of testicular function. J. Clin. Oncol. 3: 1232-1239, 1985.
57. Sharpe, R. M. & Skakkebæk, N. E.: Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341: 1392-1395, 1993.
58. Strader, C. H., Weiss, N. S., Daling, J. R., Karagas, M. R. & McKnight, B.: Cryptorchism, orchiopexy, and the risk of testicular cancer. Am. J. Epidemiol. 127: 1013-1018, 1988.
59. Swerdlow, A. J., Huttly, S. R. A. & Smith, P. G.: Testis Cancer: post-natal factors., sexual behaviour and fertility. Int. J. Cancer 43: 549-553, 1989.
60. Toppari, J., Larsen, J. C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L. J. J., Jégmi, B., Jensen, T. K., Jouannet, P., Keiding, N. et al.: Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. (Suppl. 104): 741-803, 1996.
61. Van Waeleghem, K., De Clercq, N., Vermeulen, L., Schoonjans, F. & Comhaire, F.: Deterioration of sperm quality in young healthy Belgian men. Hum. Reprod. 11: 325-329, 1996.
62. von der Maase, H., Rorth, M., Walbom-Jorgensen, S., Sorensen, B. L., Christophersen, I. S., Hald, T., Jacobsen, G. K., Berthelsen, J. G. & Skakkebæk, N. E.: Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br. Med. J. 293: 1398-1401, 1986.
63. Weissbach, L., Boedefeld, E. A. & Horstmann-Dubral, B.: Surgical Treatment of Stage-1 nonSeminomatous Germ Cell Testis Tumor. Eur. Urol. 17: 97-106, 1990.
64. Willemse, P. H. B., Sleijfer, D. T., Sluiter, W. J., Schraffordt Koops, H. & Doorenbos, H.: Altered Leydig cell function in patients with testicular cancer: evidence for a bilateral testicular defect. Acta Endocrinol. 102: 616-624, 1983.